Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Tolerance of THC 25: CBD 25 in Patients With Severe Pruritus: a Multicenter, Double-blind, Randomized, Placebo-controlled Study

NCT06435299 is registered in ClinicalTrials.gov with University Hospital, Brest as lead sponsor.

NCT NCT06435299
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06435299 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Tolerance of THC 25: CBD 25 in Patients With Severe Pruritus: a Multicenter, Double-blind, Randomized, Placebo-controlled Study
Lead sponsor
University Hospital, Brest
Phase
Phase 2
Overall status
Not yet recruiting
Start date
January 1, 2027
Completion date
March 1, 2029
Enrollment
218 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

pruritus